Mini Review
Published on 12 Mar 2025
Could antidepressants increase mood and immunity at the same time?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1340179
- 1,423 views
Type at least 3 characters
559 articles
Original Research
Accepted on 07 Mar 2025
Postmarketing Safety Assessment of the Novel Postpartum Depression Drug, Zuranolone: Evidence from Real-World Pharmacovigilance Analysis Based on the FDA Adverse Event Reporting System (FAERS)
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1517773
- 369 views
Brief Research Report
Published on 05 Mar 2025
Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreening
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1450111
- 841 views
- 1 citation
Original Research
Published on 04 Mar 2025
Long-term effectiveness, adherence and safety of twice-yearly paliperidone-palmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the paliperdone-2 per year study (P2Y)
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1540213
- 1,796 views
Original Research
Published on 03 Mar 2025
Exposure and response prevention versus risperidone for the treatment of tic disorders: a randomized controlled trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1360895
- 1,427 views
Editorial
Published on 13 Feb 2025
Editorial: Case reports in psychopharmacology, volume II
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1554037
- 679 views
Original Research
Published on 05 Feb 2025
Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1506142
- 1,808 views
Case Report
Published on 03 Feb 2025
Treatment of neuropathic pain with repeated low-dose MDMA: a case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1513022
- 3,864 views
Perspective
Published on 23 Jan 2025
Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1433999
- 2,284 views
Review
Published on 10 Jan 2025
A systematic review and meta-analysis of the effects of combined aripiprazole on glycolipid metabolism in schizophrenia
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1496986
- 1,292 views
Correction
Published on 23 Dec 2024
Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1523364
- 536 views
Original Research
Published on 20 Dec 2024
Clinical pharmacist recommendations in daily interdisciplinary ward rounds at a psychiatric hospital: a retrospective pre-post study on drug-related problems focused in somatic comorbidities
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1473832
- 924 views
- 1 citation
Original Research
Published on 09 Dec 2024
Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1471457
- 1,200 views
Systematic Review
Published on 09 Dec 2024
Phytochemicals in the treatment of patients with depression: a systemic review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1509109
- 2,915 views
- 1 citation
Case Report
Published on 04 Dec 2024
Pregabalin treatment in a 30-year-old patient with Bainbridge-Ropers syndrome: a case-report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1502773
- 1,836 views
- 1 citation
Systematic Review
Published on 04 Dec 2024
Prevalence and solving strategies of drug-related problems in adult psychiatric inpatients - a systematic review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1460098
- 1,541 views